Our verdict is Pathogenic. The variant received 10 ACMG points: 10P and 0B. PM1PM2PP2PP3_StrongPP5
The NM_000257.4(MYH7):c.4823G>C(p.Arg1608Pro) variant causes a missense change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R1608L) has been classified as Uncertain significance.
MYH7 (HGNC:7577): (myosin heavy chain 7) Muscle myosin is a hexameric protein containing 2 heavy chain subunits, 2 alkali light chain subunits, and 2 regulatory light chain subunits. This gene encodes the beta (or slow) heavy chain subunit of cardiac myosin. It is expressed predominantly in normal human ventricle. It is also expressed in skeletal muscle tissues rich in slow-twitch type I muscle fibers. Changes in the relative abundance of this protein and the alpha (or fast) heavy subunit of cardiac myosin correlate with the contractile velocity of cardiac muscle. Its expression is also altered during thyroid hormone depletion and hemodynamic overloading. Mutations in this gene are associated with familial hypertrophic cardiomyopathy, myosin storage myopathy, dilated cardiomyopathy, and Laing distal myopathy. [provided by RefSeq, May 2022]
MHRT (HGNC:51291): (myosin heavy chain associated RNA transcript) This gene encodes a spliced long non-coding RNA that may act as a cardioprotective agent in the heart. Based on a study of a similar gene in mouse, the encoded transcript may regulate chromatin remodeling by acting as a decoy to the BRG1 chromatin repressor complex thus preventing it from binding to its genomic targets. Blocking the actions of BRG1 could be crucial in protecting the heart from pathological hypertrophy. [provided by RefSeq, Dec 2014]
Our verdict: Pathogenic. The variant received 10 ACMG points.
PM1
In a hotspot region, there are 2 aminoacids with missense pathogenic changes in the window of +-8 aminoacids around while only 0 benign, 26 uncertain in NM_000257.4
PM2
Very rare variant in population databases, with high coverage;
PP2
Missense variant in the MYH7 gene, where missense mutations are typically associated with disease (based on misZ statistic). The gene has 341 curated pathogenic missense variants (we use a threshold of 10). The gene has 16 curated benign missense variants. Gene score misZ: 3.9329 (above the threshold of 3.09). Trascript score misZ: 6.7889 (above the threshold of 3.09). GenCC associations: The gene is linked to myopathy, myosin storage, autosomal recessive, MYH7-related skeletal myopathy, congenital myopathy 7A, myosin storage, autosomal dominant, Ebstein anomaly, hyaline body myopathy, left ventricular noncompaction, hypertrophic cardiomyopathy 1, dilated cardiomyopathy 1S, dilated cardiomyopathy, congenital heart disease, familial isolated dilated cardiomyopathy, myopathy, myosin storage, autosomal dominant, arrhythmogenic right ventricular cardiomyopathy, hypertrophic cardiomyopathy.
PP3
MetaRNN computational evidence supports a deleterious effect, 0.94
PP5
Variant 14-23416134-C-G is Pathogenic according to our data. Variant chr14-23416134-C-G is described in CliVar as Pathogenic. Clinvar id is 143212.Status of the report is no_assertion_criteria_provided, 0 stars. Variant chr14-23416134-C-G is described in CliVar as Pathogenic. Clinvar id is 143212.Status of the report is no_assertion_criteria_provided, 0 stars. Variant chr14-23416134-C-G is described in CliVar as Pathogenic. Clinvar id is 143212.Status of the report is no_assertion_criteria_provided, 0 stars. Variant chr14-23416134-C-G is described in CliVar as Pathogenic. Clinvar id is 143212.Status of the report is no_assertion_criteria_provided, 0 stars. Variant chr14-23416134-C-G is described in CliVar as Pathogenic. Clinvar id is 143212.Status of the report is no_assertion_criteria_provided, 0 stars. Variant chr14-23416134-C-G is described in CliVar as Pathogenic. Clinvar id is 143212.Status of the report is no_assertion_criteria_provided, 0 stars. Variant chr14-23416134-C-G is described in CliVar as Pathogenic. Clinvar id is 143212.Status of the report is no_assertion_criteria_provided, 0 stars. Variant chr14-23416134-C-G is described in CliVar as Pathogenic. Clinvar id is 143212.Status of the report is no_assertion_criteria_provided, 0 stars. Variant chr14-23416134-C-G is described in CliVar as Pathogenic. Clinvar id is 143212.Status of the report is no_assertion_criteria_provided, 0 stars. Variant chr14-23416134-C-G is described in CliVar as Pathogenic. Clinvar id is 143212.Status of the report is no_assertion_criteria_provided, 0 stars. Variant chr14-23416134-C-G is described in CliVar as Pathogenic. Clinvar id is 143212.Status of the report is no_assertion_criteria_provided, 0 stars. Variant chr14-23416134-C-G is described in CliVar as Pathogenic. Clinvar id is 143212.Status of the report is no_assertion_criteria_provided, 0 stars. Variant chr14-23416134-C-G is described in CliVar as Pathogenic. Clinvar id is 143212.Status of the report is no_assertion_criteria_provided, 0 stars. Variant chr14-23416134-C-G is described in CliVar as Pathogenic. Clinvar id is 143212.Status of the report is no_assertion_criteria_provided, 0 stars. Variant chr14-23416134-C-G is described in CliVar as Pathogenic. Clinvar id is 143212.Status of the report is no_assertion_criteria_provided, 0 stars. Variant chr14-23416134-C-G is described in CliVar as Pathogenic. Clinvar id is 143212.Status of the report is no_assertion_criteria_provided, 0 stars. Variant chr14-23416134-C-G is described in CliVar as Pathogenic. Clinvar id is 143212.Status of the report is no_assertion_criteria_provided, 0 stars. Variant chr14-23416134-C-G is described in CliVar as Pathogenic. Clinvar id is 143212.Status of the report is no_assertion_criteria_provided, 0 stars. Variant chr14-23416134-C-G is described in CliVar as Pathogenic. Clinvar id is 143212.Status of the report is no_assertion_criteria_provided, 0 stars. Variant chr14-23416134-C-G is described in CliVar as Pathogenic. Clinvar id is 143212.Status of the report is no_assertion_criteria_provided, 0 stars. Variant chr14-23416134-C-G is described in CliVar as Pathogenic. Clinvar id is 143212.Status of the report is no_assertion_criteria_provided, 0 stars. Variant chr14-23416134-C-G is described in CliVar as Pathogenic. Clinvar id is 143212.Status of the report is no_assertion_criteria_provided, 0 stars. Variant chr14-23416134-C-G is described in CliVar as Pathogenic. Clinvar id is 143212.Status of the report is no_assertion_criteria_provided, 0 stars. Variant chr14-23416134-C-G is described in CliVar as Pathogenic. Clinvar id is 143212.Status of the report is no_assertion_criteria_provided, 0 stars. Variant chr14-23416134-C-G is described in CliVar as Pathogenic. Clinvar id is 143212.Status of the report is no_assertion_criteria_provided, 0 stars. Variant chr14-23416134-C-G is described in CliVar as Pathogenic. Clinvar id is 143212.Status of the report is no_assertion_criteria_provided, 0 stars. Variant chr14-23416134-C-G is described in CliVar as Pathogenic. Clinvar id is 143212.Status of the report is no_assertion_criteria_provided, 0 stars. Variant chr14-23416134-C-G is described in CliVar as Pathogenic. Clinvar id is 143212.Status of the report is no_assertion_criteria_provided, 0 stars. Variant chr14-23416134-C-G is described in CliVar as Pathogenic. Clinvar id is 143212.Status of the report is no_assertion_criteria_provided, 0 stars. Variant chr14-23416134-C-G is described in CliVar as Pathogenic. Clinvar id is 143212.Status of the report is no_assertion_criteria_provided, 0 stars. Variant chr14-23416134-C-G is described in CliVar as Pathogenic. Clinvar id is 143212.Status of the report is no_assertion_criteria_provided, 0 stars. Variant chr14-23416134-C-G is described in CliVar as Pathogenic. Clinvar id is 143212.Status of the report is no_assertion_criteria_provided, 0 stars. Variant chr14-23416134-C-G is described in CliVar as Pathogenic. Clinvar id is 143212.Status of the report is no_assertion_criteria_provided, 0 stars. Variant chr14-23416134-C-G is described in CliVar as Pathogenic. Clinvar id is 143212.Status of the report is no_assertion_criteria_provided, 0 stars. Variant chr14-23416134-C-G is described in CliVar as Pathogenic. Clinvar id is 143212.Status of the report is no_assertion_criteria_provided, 0 stars. Variant chr14-23416134-C-G is described in CliVar as Pathogenic. Clinvar id is 143212.Status of the report is no_assertion_criteria_provided, 0 stars. Variant chr14-23416134-C-G is described in CliVar as Pathogenic. Clinvar id is 143212.Status of the report is no_assertion_criteria_provided, 0 stars. Variant chr14-23416134-C-G is described in CliVar as Pathogenic. Clinvar id is 143212.Status of the report is no_assertion_criteria_provided, 0 stars. Variant chr14-23416134-C-G is described in CliVar as Pathogenic. Clinvar id is 143212.Status of the report is no_assertion_criteria_provided, 0 stars. Variant chr14-23416134-C-G is described in CliVar as Pathogenic. Clinvar id is 143212.Status of the report is no_assertion_criteria_provided, 0 stars. Variant chr14-23416134-C-G is described in CliVar as Pathogenic. Clinvar id is 143212.Status of the report is no_assertion_criteria_provided, 0 stars. Variant chr14-23416134-C-G is described in CliVar as Pathogenic. Clinvar id is 143212.Status of the report is no_assertion_criteria_provided, 0 stars. Variant chr14-23416134-C-G is described in CliVar as Pathogenic. Clinvar id is 143212.Status of the report is no_assertion_criteria_provided, 0 stars.